|
UBE2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0418999996098E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.8455999979733E-08 |
| Normal-vs-Stage2 |
4.341100E-03 |
| Normal-vs-Stage3 |
2.600200E-04 |
| Normal-vs-Stage4 |
1.335310E-03 |
| Stage1-vs-Stage2 |
5.565400E-01 |
| Stage1-vs-Stage3 |
4.188200E-01 |
| Stage1-vs-Stage4 |
4.854400E-01 |
| Stage2-vs-Stage3 |
3.286000E-01 |
| Stage2-vs-Stage4 |
3.461600E-01 |
| Stage3-vs-Stage4 |
9.973800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.04219999086786E-09 |
| Normal-vs-AfricanAmerican |
1.709530E-02 |
| Normal-vs-Asian |
6.448800E-01 |
| Caucasian-vs-AfricanAmerican |
3.063800E-02 |
| Caucasian-vs-Asian |
1.354350E-01 |
| AfricanAmerican-vs-Asian |
1.686240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84610000012009E-08 |
| Normal-vs-Female |
2.30539999999113E-05 |
| Male-vs-Female |
5.660800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.946200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.8109999999627E-07 |
| Normal-vs-Age(61-80Yrs) |
1.83919999996451E-06 |
| Normal-vs-Age(81-100Yrs) |
2.717100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.422300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.363700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.223400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.421400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.664300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.589830E-02 |
| Normal-vs-Grade 2 |
6.49419995557565E-09 |
| Normal-vs-Grade 3 |
2.22670000005198E-06 |
| Normal-vs-Grade 4 |
2.224400E-01 |
| Grade 1-vs-Grade 2 |
9.213000E-01 |
| Grade 1-vs-Grade 3 |
3.928000E-01 |
| Grade 1-vs-Grade 4 |
1.034360E-01 |
| Grade 2-vs-Grade 3 |
7.845600E-02 |
| Grade 2-vs-Grade 4 |
4.724400E-03 |
| Grade 3-vs-Grade 4 |
3.855800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.91175980496428E-12 |
| Normal-vs-ccB subtype |
3.803900E-02 |
| ccA subtype-vs-ccB subtype |
2.59640000055406E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.01349999959544E-07 |
| Normal-vs-N1 |
9.580800E-01 |
| N0-vs-N1 |
9.037600E-02 |
|
|
